Detection of Chromosomal Structural Alterations in Single Cells by SNP Arrays: A Systematic Survey of Amplification Bias and Optimized Workflow by Iwamoto, Kazuya et al.
Detection of Chromosomal Structural Alterations in
Single Cells by SNP Arrays: A Systematic Survey of
Amplification Bias and Optimized Workflow
Kazuya Iwamoto
1*, Miki Bundo
1, Junko Ueda
1, Yoko Nakano
1, Wataru Ukai
2, Eri Hashimoto
2, Toshikazu Saito
2, Tadafumi Kato
1
1Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Wako, Saitama, Japan, 2Department of Neuropsychiatry,
Sapporo Medical University, Chuo-Ku, Sapporo, Japan
Background. In single-cell human genome analysis using whole-genome amplified product, a strong amplification bias
involving allele dropout and preferential amplification hampers the quality of results. Using an oligonucleotide single
nucleotide polymorphism (SNP) array, we systematically examined the nature of this amplification bias, including frequency,
degree, and preference for genomic location, and we assessed the effects of this amplification bias on subsequent genotype
and chromosomal copy number analyses. Methodology/Principal Findings. We found a large variability in amplification bias
among the amplified products obtained by multiple displacement amplification (MDA), and this bias had a severe effect on the
genotype and chromosomal copy number analyses. We established optimal experimental conditions for pre-screening for
high-quality amplified products, processing array data, and analyzing chromosomal structural alterations. Using this optimized
protocol, we successfully detected previously unidentified chromosomal structural alterations in single cells from a
lymphoblastoid cell line. These alterations were subsequently confirmed by karyotype analysis. In addition, we successfully
obtained reproducible chromosomal copy number profiles of single cells from the cell line with a complex karyotype,
indicating the applicability and potential of our optimized workflow. Conclusions/Significance. Our results suggest that the
quality of amplification products should be critically assessed before using them for genomic analyses. The method of MDA-
based whole-genome amplification followed by SNP array analysis described here will be useful for exploring chromosomal
alterations in single cells.
Citation: Iwamoto K, Bundo M, Ueda J, Nakano Y, Ukai W, et al (2007) Detection of Chromosomal Structural Alterations in Single Cells by SNP Arrays:
A Systematic Survey of Amplification Bias and Optimized Workflow. PLoS ONE 2(12): e1306. doi:10.1371/journal.pone.0001306
INTRODUCTION
Single-cell human genome analysis is critically important for basic
and medicalgenetics. Somatic genomicdifferencesare found inboth
normal cellular differentiation, as seen in the immune system, and in
the progression of diseases such as cancer. In addition, genomic
differences within neurons of an individual, as seen in aneuploidy,
have also been proposed to contribute to neuronal complexity [1–3].
Technical difficulties have hampered genomic studies using
single cells because many analytic techniques require considerable
amounts of genomic DNA (gDNA). A number of whole-genome
amplification (WGA) methods [4,5] and their application to single
cells have been developed to overcome this obstacle. However,
single-cell WGA (S-WGA) methods are notoriously susceptible to
strong amplification bias [6] such as the failure of amplification of
one of the two alleles (allele dropout, AD) and excess amplification
of one allele or unequal amplification of the two alleles (prefer-
ential amplification, PA). Conventional PCR-based WGA meth-
ods such as degenerate oligonucleotide primed PCR (DOP-PCR)
[7–10], primer extension preamplification (PEP) [11–14], and the
linker-adaptor ligation-based method [15,16] have been used to
amplify DNA extracted from a small number of cells. However,
these methods do not allow researchers to examine the amplifi-
cation bias in a genome-wide manner. The genome regions to be
amplified are known to be biased and limited in the conventional
PCR-based methods. In addition, amplified products obtained by
PCR-based WGA methods are generally too short in length to
apply genome-wide single nucleotide polymorphism (SNP) geno-
typing technologies. In one PCR-based S-WGA method [17,18], a
less-biased genome amplification was proposed. However, it is still
difficult to apply genome-wide SNP genotyping analysis to the
product obtained by this method, due to the random fragmenta-
tion of gDNA and short product length.
Recently, multiple displacement amplification (MDA)-based
WGA with a phi29 DNA polymerase, which yields less-biased and
longer (.10 kb) amplified products [19], has been applied to a
small number of cells. In the case of MDA from a small number of
cells, consistent genotype and chromosomal copy number (CCN)
profiles can be obtained from about 1,000 to 1,500 cells, and well-
optimized experimental conditions have already been established
[20–24]. Although MDA-based WGA has also been applied to
single cells [6,25–27], the knowledge of amplification biases, such
as the frequency, degree, and preference for genomic location in
the S-WGA products at the single-cell level has been very limited,
and their effects on down-stream analyses have been poorly
examined until now.
Here we performed a high-density oligonucleotide SNP array
analysis of the MDA-based S-WGA products from a lymphoblas-
toid cell line (LCL) and a cell line having a complex karyotype. We
Academic Editor: Jean-Nicolas Volff, Ecole Normale Supe ´rieure de Lyon,
France
Received August 29, 2007; Accepted November 16, 2007; Published December
12, 2007
Copyright:  2007 Iwamoto et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: This work was supported by a Grant-in-Aid from the Japanese Ministry
of Health, Welfare, and Labor.
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: kaziwamoto@brain.
riken.jp
PLoS ONE | www.plosone.org 1 December 2007 | Issue 12 | e1306examined the nature of the amplification bias using genome-wide
genotype information, and assessed its effect on the CCN analysis.
We also developed a SNP array data analysis approach to
discriminate CCN alterations from amplification bias artifacts,
which will be useful for exploring the chromosomal alterations in
single cells.
RESULTS
S-WGA from LCL and Taqman genotyping assay
We performed MDA-based S-WGA in 40 single cells obtained from
oneLCL(Figure 1). Among the 40 single cells, 16 were processed by
protocol 1 and 24 were processed by protocol 2 (see Materials and
Methods). We did not observe degradation of the starting gDNA
(data notshown)ordifferencesinsizedistributionamong theS-WGA
products, except for one sample with a lower yield than the others
(Figure 1). The S-WGA products were genotyped for 23 SNPs,
covering all autosomes and X chromosomes, using a fluorogenic 59-
nuclease (Taqman) assay (Table S1). The non-amplified gDNA of
this LCL was found to be homozygous for 17 SNPs and heterozygous
for 6 SNPs. With regard to the 17 homozygous SNPs in the non-
amplified gDNA, none of the genotyped alleles in the S-WGA
products showed inconsistent genotypes. On the other hand, we
observed various degrees of amplification bias in the S-WGA
products, involving the 6 heterozygous SNPs in the non-amplified
gDNA (Figure 2A and Figure S1). We therefore manually
determined the genotypes of the heterozygous alleles based on the
fluorescence intensities of the Taqman assay, and classified them into
the following categories: heterozygous (allele AB), PA, AD or failure
(Figure 2B). We found that only 10.4% of the genotyped SNPs
showed up as heterozygous, and the other SNPs showed a failure or
amplification bias. (Figure 2C).
Among the 40 S-WGA products genotyped, we selected a total
of 12 products for the SNP array analysis. We found that the rate
of successfully genotyped alleles (call rate) on the array was
modestly correlated with the concordance rate of heterozygous
SNPs by the Taqman assay, if both PA and AB were considered to
be successfully genotyped as heterozygous (R=0.467, Figure 2D).
Genotype analysis of S-WGA products from LCL
using SNP arrays
We found that the call rate on the SNP array was strongly
correlated with the global genotype concordance between S-WGA
products and non-amplified gDNA obtained by SNP array
(R=0.982, Figure 3). The heterozygous SNPs in the non-
amplified gDNA showed lower concordance (average6SD,
31.4621.1%) among S-WGA products, compared with the
homozygous SNPs (82.1611.7%, Figure 3).
To test whether the genomic location influences the amplifica-
tion efficiency of MDA, we used the homozygous SNPs in the
array data for analysis. The homozygous SNPs in the non-
amplified gDNA were divided into three groups by genomic
location: close to a centromere, close to a telomere (p arm or q
arm), or located elsewhere. We found that SNPs close to
centromeres or telomeres showed significantly lower genotype
concordance between non-amplified gDNA and S-WGA products,
compared with those located in other genomic regions (Figure
S2). In addition, we observed that certain chromosomes, such as
19 and 22, tend to show discordant genotypes between non-
amplified gDNA and S-WGA products (Figure 4).
We then examined whether genomic location influences the
amplification bias using heterozygous SNPs in the non-amplified
gDNA for analysis. In contrast to the homozygous SNPs, we
observed that the heterozygous SNPs that showed discordant
genotypes between non-amplified gDNA and S-WGA products
were dispersed throughout the genome (Figure S2), suggesting a
stochastic occurrence of AD in a genome-wide manner.
We then tested whether genome GC content (GC%) influences
amplification bias. To this end, heterozygous SNPs in the non-
amplified gDNA were used for analysis (Figure S2). We first
excluded the heterozygous SNPs located close to the centromeres
or telomeres described above. Among the remaining heterozygous
SNPs, 2.6% (290 SNPs) were genotyped as homozygous or no calls
in all of the 10 S-WGA products. We did not observe a preference
for genomic location for these SNPs (data not shown), but found
that the genome GC% slightly but significantly (P,0.01, t-test)
affected the genotype concordance (Figure S2).
Among the 290 discordant SNPs, we used 154 whose genotype
was homozygous in greater than five S-WGA products (i.e., non-
no call SNPs) for further analysis. We then divided these SNPs into
two groups: SNPs showing biased AD of one allele (i.e., the
genotype call of each SNP tended to be exclusively one
homozygous allele, at least 75% AA or BB) and other SNPs (i.e.,
the genotype call of each SNP was a mixture of two homozygous
alleles, AA and BB). We found that a total of 74 SNPs showed a
biased AD of one allele, and 80 SNPs showed non-biased AD. We
did not observe the preference for genomic location for the SNPs
showing the biased AD of one allele (data not shown). However,
these SNPs showed statistically higher GC% (40.2%) compared
with other SNPs (38.0%, P,0.05, t-test). These results suggest that
genome GC% affects both the occurrence of AD and the
preference of AD between two alleles to some extent.
CCN analysis in the S-WGA products from LCL using
SNP arrays
Accuracy of the CCN analysis, assessed by the standard deviation
of the signal log2 ratio, was also strongly dependent on the call rate
on the array (R=0.885, Figure 5A). Consistency of the CCN
data between S-WGA products and non-amplified gDNA was
progressively lost in the S-WGA products showing lower call rates.
Similar to the genotype analysis described above, we also tested
whether genomic location influences the CCN analysis by using
both homozygous and heterozygous SNPs in the SNP array
together. Genomic regions showing a frequent genotype discor-
dance such as regions close to centromeres and telomeres showed
statistically weaker signal log2 ratios compared with other genomic
regions (Figure S2). We observed a strong correlation between
genotype concordance and signal log2 ratio (R=0.980 and 0.823
Figure 1. Visualization of the S-WGA products from a LCL by gel
electrophoresis. We loaded 1 ml of each S-WGA reaction mixture
obtained by protocol 2 (N=24). A sample indicated by an asterisk was
not selected for further analysis based on the results of the Taqman
genotyping assay.
doi:10.1371/journal.pone.0001306.g001
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chromosomes that showed discordant genotypes such as chromo-
somes 19 and 22 also showed weaker signal log2 ratios compared
to other chromosomes (Figure 4).
To correct for these effects of amplification bias on CCN
analysis, we developed a two-step examination of the candidate
regions for chromosomal alterations. In the first step, CCN
analysis of an S-WGA product was performed using a set of non-S-
WGA products as reference, and candidate CCN alterations were
identified. In the second step, CCN analysis of the S-WGA
product was performed by using another set of S-WGA products
as reference, and candidate regions were re-examined. By
changing the reference, the CCN data can be successfully
normalized in the insufficiently amplified regions, such as
chromosome 19 and 22 (Figure 5B, C). Unexpectedly, we found
that two S-WGA products showed a weak signal log2 ratio in a
large part of chromosome 6q (20%), even after the normalization
by other S-WGA SNP array data (Figure 5D). In that region,
we also detected a considerable loss of heterozygous SNPs
(Figure 5D). Subsequent karyotype analysis in this LCL revealed
a deletion in chromosome 6q in four of the 14 cells analyzed (29%)
(Figure 5E). This finding provided evidence that the weak signal
log2 ratio observed in that region was not a technical artifact but
reflects a true chromosomal deletion, demonstrating the appro-
priateness of our data analysis for the detection of chromosome
structural alterations at the single cell level.
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Figure 2. Amplification bias and manual genotyping of the heterozygous SNP. (A) Amplification bias revealed by the Taqman genotyping assay.
The relative fluorescence intensities of alleles A and B in each sample with regard to rs1895694 are shown. Fluorescence intensities of the S-WGA
products obtained by protocol 2 (N=24) are shown. The results from another 5 heterozygous SNPs can be found in Figure S1.( B) Manual genotyping
of rs1895694 in the S-WGA products. AB, heterozygous (allele AB); PA, preferential amplification; AD, allele dropout; Failed, failure in WGA. (C)
Summary of the manual genotyping of the heterozygous SNPs. The percentage was calculated from a total of 240 data points obtained from
genotyping of 6 heterozygous SNPs in 40 S-WGA products. (D) Concordance rate of the heterozygous SNPs by Taqman genotyping assay correlated
with call rate on the SNP array. The data from 12 S-WGA products derived from a LCL and 3 S-WGA products derived from the CMK11-5 are shown.
Genotyping results of 6 heterozygous SNPs (rs1895694, rs4706387, rs2074711, rs1007971, rs4140571, and rs2280964 for a LCL; rs1895694, rs7110302,
rs11657541, rs1217617, rs9991, and rs2268248 for the CMK11-5) by Taqman assay were used for calculation of concordance rate. In genotyping S-
WGA products, the heterozygous SNP as well as PA-classified SNPs were considered to be concordant with non-amplified gDNA. The blue squares
and diamonds indicate the S-WGA products obtained by protocol 1 and 2, respectively.
doi:10.1371/journal.pone.0001306.g002
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CMK11-5 line using SNP arrays
The success in the detection of chromosomal deletion in the LCL
allowed us to assess the ability of our approach to detect complex
chromosomal abnormalities. We next performed CCN analysis of
the S-WGA products from the CMK11-5 cell line, one of the
derivatives of the CMK line. The CMK line was established from
a patient with Down syndrome [28], and known to show complex
hypo-tetraploidy. We confirmed that the CMK11-5 also showed
complex hypo-tetraploidy and that this has a different karyotype
compared with the parental CMK line (Figure S3).
With regard to the 23 SNPs used for genotyping by the Taqman
assay, the non-amplified gDNA of CMK11-5 was found to be
homozygous for 17 SNPs and heterozygous for 6 SNPs. After the
S-WGA and subsequent Taqman assay of the 24 products, a total
of 3 were selected for SNP array analysis. Similar to the LCL
experiment, the call rates on the SNP array were strongly
associated with the Taqman genotype concordance of heterozy-
gous SNPs, when AB and PA-classified genotypes were considered
to be concordant (Figure 2D).
As predicted, concordance of the genotypes and the CCN
profiles between the S-WGA products and non-amplified gDNA
was dependent on the call rate on the array (Figure 3 and
Figure 6A). Nevertheless, the CCN profiles of 3 S-WGA products
were very similar, supporting the reproducibility of the S-WGA
and SNP array analysis in this cell line (Figure 6A).
We next analyzed various parameters in the CCN analysis using
the Copy Number Analysis Tool (CNAT) 4.1 software. The
optimal genomic smoothing size in the CCN analysis (s, copy
number state of each SNP was calculated using all flanking SNPs
within 2s to the left and right) is generally dependent on the type
of analysis. We needed a genomic smoothing size of 2–3 Mb with
about 80% of the call rate on the array to obtain consistent data
with non-amplified gDNA (Figure 6B). For detecting chromo-
somal alterations in the CMK lines such as del(3)(p14), del(9)(p21)
and additional chromosome 21, a genomic smoothing size of 1 Mb
was sufficient (Figure 6B). Due to the limited resolution of the
karyotype by the G-band and the existence of multiple marker
chromosomes (Figure S3), determining the precise relationship
between karyotype and CCN data was beyond the scope of the
current study.
DISCUSSION
The large variability in amplification bias among S-WGA
products, and the severe effect of amplification bias on the
genotype and CCN analysis, suggest that the quality of S-WGA
products should be critically assessed before starting down-stream
analyses. It should be noted that size distribution and product yield
did not differ among the S-WGA products, indicating that simple
electrophoresis and DNA quantification cannot help the assess-
ment of the product quality. Although only modest correlation was
obtained, Taqman genotyping of heterozygous SNPs with
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SNP array call rate and screening for the products with potentially
high quality (i.e., low rate of AD and less-biased genome
amplification).
Because the amplification bias was seen, more or less, at every
heterozygous SNP (Figure S1), we determined the genotypes
arbitrarily by defining the thresholds in the Taqman genotyping
assay (see Materials and Methods). In addition to AD, we
determined PA in the genotyping. By considering the PA genotype
as the heterozygous SNP, we observed correlation between the
Taqman assay and SNP array call rate. We did not observe any
correlation when we used other genotypes for calculation, such as
homozygous SNPs, or heterozygous SNPs without consideration
for PA (data not shown). Although changing the thresholds in the
Taqman genotyping affected the results to some extent, the
relationship between genotype concordance rate by the Taqman
assays and the call rate on the SNP array (Figure 2D) was stably
detected (data not shown). It should be noted that the Taqman
genotyping assays were not suitable for quantitative purposes.
However, considering that the fluorescence intensity was obtained
at the endpoint of the assay, using positive controls of non-
amplified gDNAs generally resulted in rigorous and reproducible
fluorescence intensities for threshold determination.
Selecting the S-WGA products showing a concordance rate
greater than 60% by Taqman assay of the heterozygous SNPs for
the subsequent SNP array analysis generally resulted in call rates
of at least 80% (Figure 2D). SNP array data with such a high call
rate ensure a relatively low level of AD (average genotype
concordance in the heterozygous SNPs was 41.7%, Figure 3) and
a precise CCN profile for single cells with complex chromosomal
structural alterations (Figure 6). It should be noted that we used 6
heterozygous SNPs for calculation. Among the 40 S-WGA
products from the LCL, only about one-fourth of the products
showed more than 60% concordance by the Taqman assay (data
not shown). Increasing the number of heterozygous SNPs for the
Taqman assay will improve this predictive ability. In addition, it
has been recently reported that amplification bias in MDA can be
ameliorated by reducing the reaction volume using nanoliter
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easily screen high quality S-WGA product.
We found that genomic location of the homozygous SNPs that
showed discordant genotypes in the S-WGA products was mainly
localized to the regions close to centromeres or telomeres (Figure
S2). It has been known that repetitive genomic regions such as
telomeres and centromeres tend to be underrepresented by MDA
[19].
In addition, we observed that chromosomes such as 19 and 22
showed weak signal log2 ratio in the CCN analysis. Although the
reason for this is not clear, this may not be specific to S-WGA, but
rather a characteristic of the MDA-based WGA to some extent,
because the signal log2 ratio in the WGA product using 10 ng of
non-amplified gDNA as starting material also showed a slightly
decreased signal log2 ratio in chromosome 19 (Figure 5B). It has
been reported that specific chromosomal regions such as 1q42,
4q35, and 6p25 showed loss of representation after MDA [30],
although these regions were not replicated in our previous study
[31] or in the current study using S-WGA products. Recent array
CGH analysis using the MDA products from a small number of
cells isolated by laser capture-microdissected cells also revealed a
reproducible biased-amplification of the genomic regions includ-
ing telomeres and some chromosomes [23,24]. In addition, in
recent S-WGA studies, insufficient chromosome amplifications in
the S-WGA products were found in both PCR- and MDA-based
WGA using array CGH techniques [25,32,33], suggesting that
some chromosomes are difficult to amplify by the S-WGA
experiments.
Although we observed that genome GC content affects both
occurrence of AD and preference of AD between two alleles to
some extent, we found that AD occurred throughout the genome
in addition to the insufficiently amplified genomic regions. These
results indicate that genotyping the heterozygous SNPs at the
single-cell level for medical purposes should be done cautiously,
even in cases where high-quality S-WGA products can be used for
analysis.
Unlike the array CGH analyses [18,25,33], SNP array analysis
allowed us not only to carry out high-resolution CCN analysis, but
also to apply critical quality assessment using genotype informa-
tion. In addition, our two-step examination of the candidate
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Figure 6. CCN analysis of the S-WGA products from the CMK11-5 cell line. (A) Results of the CCN analysis. A 3-Mb genomic smoothing size was
used for analysis. Blue and red lines indicate CCN data of the non-amplified gDNA and S-WGA product, respectively. (B) Effect of the genomic
smoothing size (s) on the CCN analysis. Green and red lines indicate CCN data of the non-amplified gDNA and S-WGA product, respectively.
doi:10.1371/journal.pone.0001306.g006
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CCN alterations from biased amplification. A similar normaliza-
tion principle utilizing the reproducible biased-amplification in
MDA has also been reported in array CGH analyses [23,33].
In summary, by using our optimized protocol in single cells
from the lymphoblastoid cell line, we successfully detected a
chromosomal deletion that was previously unidentified. In
addition, we successfully obtained reproducible CCN profiles of
single cells from the CMK11-5 cell line with a complex karyotype.
The MDA-based S-WGA followed by the SNP array analysis
described here will be useful for exploring chromosomal
alterations in single cells.
MATERIALS AND METHODS
Cell culture and karyotyping
A LCL, which was established by standard methods from a Japanese
female subject, was maintained and cultured as described previously
[34]. The CMK11-5 cell line was purchased from the Japanese
Collection of Research Bioresources (JCRB) and cultured according
to the provider’s instructions. Before the S-WGA experiments, cell
cultures were retrieved and washed once with phosphate-buffered
saline (PBS). Karyotype of the LCL and CMK11-5 was determined
by the G-band method (Japan SRL, Tokyo, Japan).
Manipulation of single cells
Two areas for the single-cell experiments, each equipped with
pipets, tubes and all reagents and instruments, were prepared in
different rooms. To prevent contamination from external DNA to
the reagent, one area was reserved for the preparation for reaction
mixtures only, and nucleic acids were not handled there.
Subsequent experiments were done in the other area, which was
equipped with a UV PCR Workstation (UVP, Upland, CA, USA).
Whenever possible, all equipment was UV irradiated for 30 min
before the experiment began. Single cells were retrieved by
mouth-controlled pipetting with a fine hand-drawn microcapillary
tube under a stereoscopic microscope.
S-WGA reaction
Two protocols (protocol 1 and 2) for S-WGA using a GenomiPhi
V2 kit (GE Healthcare Life Sciences, Piscataway, NJ, USA) were
provided by the manufacturer. They were similar to the method
previously reported [6,35]. Protocol 1: Single cells were transferred
into a PCR tube containing 3 ml of sample buffer. The 1.5 mlo f
lysis solution (0.4 M KOH, 10 mM EDTA, and 100 mM DTT)
was added to a tube and cells were lysed at room temperature for
10 min. 1.5 ml of neutralizing buffer (0.8 M Tris-HCl, pH8.0, and
0.4 M HCl), 1.5 ml of sample buffer, 7.5 ml of amplification mix
(reaction buffer:enzyme mix=9:1) were added to a tube. The
reaction mixture was then incubated at 30uC for 4 hours followed
by heat inactivation at 65uC for 10 min. Protocol 2: Single cells
were transferred into a PCR tube containing 3 ml of sample buffer.
The 1.5 ml of lysis solution 2 (0.6 M KOH, 10 mM EDTA, and
100 mM DTT) was then added to a tube and cells were lysed at
30uC for 10 min. 1.5 ml of neutralizing buffer 2 (4:1 mixture of
1 M Tris-HCl pH8.0 and 3 M HCl), 4.0 ml of sample buffer, and
10 ml of amplification mix (reaction buffer:enzyme mix=9:1) were
added to a tube. The reaction mixture was then incubated at 30uC
for 4 hours followed by heat inactivation at 65uC for 10 min. In
both protocols, the sample buffer, reaction buffer, and enzyme mix
were included in the GenomiPhi V2 kit.
Despite extensive efforts, we sometimes observed amplified
products from negative control samples (PBS, distilled water, or no
addition of solution). Although they could not be distinguished from
amplified products derived from single-cell samples by the
electrophoresis or DNA quantification assays, a subsequent Taqman
genotyping assay revealed no signals from them at all 23 SNPs (see
below). Therefore, we concluded that amplification did not originate
from human DNA, but originated from the primers included in the
kit, or contamination of bacterial DNA included in the kit. Similar
observations were also reported by others [6].
InobtainingtheS-WGAproductsintheLCL,eitherprotocol1or
2wasused.Wedidnotfindconsiderabledifferencesbetweenthetwo
protocols with regardtothe yield (protocol 1,6.6560.48 mg,N=16;
protocol 2, 6.6360.52 mg, N=24), Taqman genotyping assay and
SNP array results (Figure 2). For obtaining the S-WGA products
from the CMK11-5 line, we used protocol 2.
SNP genotyping by Taqman assay
A total of 23 SNPs (one SNP for each autosome and chromosome
X, see Table S1) were chosen by the following criteria. 1) SNPs
were not included in the known copy number variations and 2) the
minor allele frequency in the Japanese population was above 0.1.
Genotyping was performed using Taqman assays (Applied
Biosystems, Foster City, CA, USA) with an ABI PRISM
7900HT (Applied Biosystems). Probes and Universal PCR Master
Mix were obtained from Applied Biosystems. In every genotyping
assay, we included the S-WGA products as well as two negative
controls (distilled water), 14 subjects for positive controls as
described below, and a non-amplified gDNA sample. In
genotyping the S-WGA products and positive control samples,
1 ml of the 5-times diluted S-WGA reaction mixture (about 70 ng)
and 10 ng of gDNA, respectively, were used as template.
Selection of the control samples for Taqman assay
To search for DNA samples suitable to serve as technical controls
in the Taqman assay of S-WGA products, we genotyped a total of
40 Japanese lymphoblastoid DNA samples. Among the 40 DNA
samples, 14 were selected for the quality control of the Taqman
assay. These DNA samples were chosen so that all three genotypes
(AA, AB, and BB) per SNP were covered by at least two subjects.
Manual determination of the genotyping by
Taqman assay
In manual determination of the genotypes of the S-WGA
products, we arbitrarily defined the following four types of
thresholds, based on the fluorescence intensities (FI) of the control
samples. The positive allele A threshold was defined as follows:
(average FI of allele A in the heterozygous alleles of the control
samples)–3 * (standard deviation of FI of allele A in the
heterozygous alleles of the control samples). Above this threshold,
allele A in the S-WGA product was considered to be amplified.
The negative allele A threshold was defined as follows: (average FI
of allele A in the homozygous allele B of the controls)+5* (standard
deviation of FI of allele A in the homozygous allele B of the
controls). If the FI of allele A in the S-WGA product was below
this threshold, allele A was considered to have dropped out of the
amplification. The positive and negative allele B thresholds were
determined the same way. Based on these thresholds, genotyping
of the heterozygous SNPs in the S-WGA products were classified
into 4 categories: AB (heterozygous, FI of both alleles were above
the positive thresholds), PA (FI of one allele was above the positive
threshold, while that of the other was not above the positive
threshold but greater than the negative threshold), AD (FI of one
allele was above the positive threshold, while that of the other was
below the negative threshold), or failed (FI of both alleles were
below the negative thresholds). An example of manual determi-
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homozygous SNPs in the S-WGA products, we did not observe
novel allele creations (for example, we never observed high FI for
allele A in a homozygous allele B genotype).
SNP array and genotype data analysis
Array data was deposited in the gene expression omnibus database
(accession no. GSE8567). An Affymetrix 50KXba chip, which
contains the probe sets for about 59,000 SNPs, was used for SNP
typing. The SNP array data of the non-amplified gDNA of the
LCL and the WGA product using 10 ng of LCL gDNA, were
previously reported [31]. The S-WGA products of LCL and
CMK11-5, as well as non-amplified gDNA of CMK11-5, were
used for the SNP array analysis in this study. The experiment was
performed according to the manufacturer’s protocol. Regardless of
the source of DNA, 250 ng of DNA was used as starting material.
The raw SNP array data was processed by Affymetrix GeneChip
Genotyping analysis (G-TYPE) software 4.1. The genotype was
determined by the Dynamic model based algorithm in the G-
TYPE software. Human genome reference of NCBI build 36 was
used for analysis. Relative genotype concordance was calculated as
follows: In each S-WGA array data set, genotype concordance rate
was calculated by chromosome, and then concordance rates were
divided by the average concordance rate (similar to per-chip
normalization). Averaged relative genotype concordance is plotted
in Figure 4.
CCN analysis
CCN analysis was performed using the CNAT4.1 (Affymetrix).
Typically, we performed unpaired sample analysis, in which one
S-WGA SNP array dataset was used as the sample and eleven
SNP array datasets from female subjects were used as reference.
Reference samples were obtained in an Asian population used in
the HapMap project. Median scaling implemented in the software
was used for per-chip normalization.
SUPPORTING INFORMATION
Table S1
Found at: doi:10.1371/journal.pone.0001306.s001 (0.03 MB
XLS)
Figure S1 Amplification bias in heterozygous SNPs revealed by
the Taqman genotyping assay. The relative fluorescence intensities
of alleles A and B are shown.
Found at: doi:10.1371/journal.pone.0001306.s002 (1.47 MB EPS)
Figure S2 (A) Genomic location of the SNPs showing inconsis-
tent genotypes or no calls in the S-WGA products compared with
non-amplified gDNA. Left, homozygous SNPs; right, heterozy-
gous SNPs. Among the 12 profiled LCL SNP array datasets, the 2
with the low quality (call rate,50%) were removed from this
analysis. Red and green bars on the chromosomes indicate the
SNPs showing low (30% or less) and high (70% and above)
consistency, respectively. Arrowheads indicate centromeres. Note
that SNPs were not located in the p arms of several chromosomes
in the Affymetrix 50K Xba SNP array. (B) Statistical analysis of
the concordance and signal log2 ratio. Concordance rates of
homozygous SNPs, or signal log2 ratio of the SNPs, in the
telomeres or centromere were compared with those in the rest of
the chromosome. Telomere SNPs included all SNPs within 10Mb
of the end. Centromere SNPs included all flanking SNPs within
the span 10Mb to the left and right of the centromere. P values by
the Student’s t-test are given. (C) Genome GC content and
genotype concordance of heterozygous SNPs.
Found at: doi:10.1371/journal.pone.0001306.s003 (2.98 MB EPS)
Figure S3 Karyotype of the CMK11-5. The CMK lines were
established from a patient with Down syndrome, and showed
hypo-tetraploidy. The CMK 11-5 was established from the CMK.
The composite karyotype of 10 cells of the CMK11-5 was as
follows: 83-90 ,4n., XYY, add(X)(p22.1)[10], add(1)(p36.3)[9],
add(1)(q21)[10], -2[10], add(2)(p21)*2[10], -3[8], add(3)(q11)[2],
del(3)(p14)*2[10], -4[9], +add(5)(q11.2)[9], add(5)(q13)[10], -6[8],
der(6)add(6)(p23)del(6)(q?)[10], der(6)add(6)del(6)[3], -7[8], -8[10],
-8[6], dup(8)(q11.2q21)[10], -9[10], -9[10], -9[7], der(9)del(9)(-
p21)add(9)(q34)[7], +10[2], del(10)(q22q24)[10], del(10)[7],
add(11)(p15)[10], der(11;17)(q10;q10)[10], -12[9], add(12)(p11.2)-
[10], add(12)[8], add(12)(p13)[10], -13[10], -13[5], -14[10], -
14[3], -15[10], -15[7], -16[4], -17[10], 18[9], add(18)(p11.2)[2],
add(18)(q23)[10], add(18)(q23)[10], -19[10], -19[6], add(19)(p13)-
[10], der(20)t(1;20)(q2?5;q1?2)*2[10], +22[3], +10-14mar.
Found at: doi:10.1371/journal.pone.0001306.s004 (4.68 MB EPS)
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